Terrific company for WearOptimo CEO and founder Professor Mark Kendall with inclusion in The Courier-Mail’s guide to SEQ’s 50 Most Inspiring Men. 

It’s a list that stretches from health-tech and charity to technology and construction, and showcases the ways in which passionate Queenslanders are competing nationally and on the world stage. 

As the name suggests, it’s inspiring reading, and even though voting in the associated poll has closed, the story remains live, so we highly encourage you to have a read here. In the meantime, here’s what the paper had to say about Mark.  

Mark is a world-renowned biomedical engineer, inventor, scientist, entrepreneur and business-builder. 
He is the founder and CEO of WearOptimo, advancing Microwearable sensors for precision medicine. 
The companies licensing his patents/technologies have generated a combined economic value of two billion dollars. 
Mark is internationally recognised as a leading innovator in producing technology solutions to global health problems; and a translator of commercial technologies focusing on delivery of drugs to skin and skin-based disease diagnostics. 
This has culminated from more than 25 years of experience researching, developing and innovating: authoring more than 200 refereed publications, and being an inventor on 150 granted patents. 
While at the University of Oxford, Mark was an inventor of the biolistics technology, commercialised with PowderJect (sold to Chiron Vaccines for one billion dollars in 2003), and then PowderMed, purchased by Pfizer for $400 million in 2006. 
Mark is a Vice-Chancellor‘s Entrepreneurial Professor at the Australian National University. 
At the University of Oxford he was a University Research Lecturer and College Lecturer.